We are live on ! Find out more
GLSI icon

Greenwich LifeSciences
GLSI

27 hedge funds and large institutions have $5.64M invested in Greenwich LifeSciences in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 4

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

19% more capital invested

Capital invested by funds: $4.75M → $5.64M (+$891K)

13% more funds holding

Funds holding: 24 → 27 (+3)

0.01% less ownership

Funds ownership: 4.18% → 4.17% (-0.01%)

Holders
27
Holders Change
+3
Holders Change %
+12.5%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
11
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
+$210K
2
6CM
683 Capital Management
New York
+$197K
3
Jane Street
Jane Street
New York
+$140K
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$134K
5
Citigroup
Citigroup
New York
+$95.5K

Top Sellers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
-$405K
2
Renaissance Technologies
Renaissance Technologies
New York
-$177K
3
Ameriprise
Ameriprise
Minnesota
-$97.8K
4
Squarepoint
Squarepoint
New York
-$97K
5
Millennium Management
Millennium Management
New York
-$76.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.33M +$17.3K +1,729 +0.8%
BlackRock
2
BlackRock
New York
$601K +$11.6K +1,158 +2%
Ameriprise
3
Ameriprise
Minnesota
$564K -$97.8K -9,757 -15%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$493K +$7.26K +724 +2%
Renaissance Technologies
5
Renaissance Technologies
New York
$385K -$177K -17,698 -33%
Northern Trust
6
Northern Trust
Illinois
$221K +$210K +20,983 New
6CM
7
683 Capital Management
New York
$206K +$197K +19,604 New
Qube Research & Technologies (QRT)
8
Qube Research & Technologies (QRT)
United Kingdom
$155K +$134K +13,404 +1,023%
Jane Street
9
Jane Street
New York
$147K +$140K +14,005 New
State Street
10
State Street
Massachusetts
$137K – – –
Millennium Management
11
Millennium Management
New York
$121K -$76.6K -7,644 -40%
Citigroup
12
Citigroup
New York
$100K +$95.5K +9,524 New
JP Morgan Chase
13
JP Morgan Chase
New York
$58.7K +$55.9K +5,574 +139,350%
Bank of America
14
Bank of America
North Carolina
$50.9K +$14.8K +1,473 +44%
UBS Group
15
UBS Group
Switzerland
$19.4K +$18.4K +1,839 +183,900%
NFSG
16
Newbridge Financial Services Group
Florida
$15.8K – – –
TRCT
17
Tower Research Capital (TRC)
New York
$15.1K +$1.4K +140 +11%
Morgan Stanley
18
Morgan Stanley
New York
$5.89K +$2.81K +280 +100%
FCMT
19
Founders Capital Management (Texas)
Texas
$5.26K – – –
GPFA
20
Game Plan Financial Advisors
Ohio
$2.1K +$2K +200 New
WTA
21
Washington Trust Advisors
Massachusetts
$2.1K +$2K +200 New
Fidelity Investments
22
Fidelity Investments
Massachusetts
$947 -$30 -3 -3%
GWM
23
Geneos Wealth Management
Colorado
$926 – – –
NSIM
24
North Star Investment Management
Illinois
$537 – – –
AF
25
Advisornet Financial
Minnesota
$526 – – –
1
2

GLSI Hedge Fund Activity: Q4 2023 in Review

27 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q4 2023, worth a combined $5.64M — up 19% from $4.75M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new GLSI positions and 3 closed out — a net gain of 3 holders — while 11 added to existing stakes and 4 trimmed.

The largest buyer was Northern Trust, opening a new position worth an estimated $210K. The largest seller was GSA Capital Partners, exiting entirely with an estimated $405K sold.

  • 27 institutional investors held Greenwich LifeSciences (GLSI) as of Q4 2023, up from 24 in Q3 2023.
  • Funds reported $5.64M of Greenwich LifeSciences stock for Q4 2023, up 19% quarter-over-quarter.
  • 6 funds opened new Greenwich LifeSciences positions in Q4 2023 and 3 closed out, a net change of +3 holders.
  • The largest Greenwich LifeSciences buyer in Q4 2023 was Northern Trust, an estimated $210K added.
  • The largest Greenwich LifeSciences seller in Q4 2023 was GSA Capital Partners, an estimated $405K sold.

Based on aggregated 13F filings for Q4 2023.